CO212 The Potential Long-Term Comparative Effectiveness of Larotrectinib Vs. Immune Checkpoint Inhibitors for Treatment of Metastatic NTRKGene Fusion-Positive Cancers
Abstract
Authors
K. Suh A. Kang G. Ko T. Williamson N. Liao S. Sullivan